DRUG
NASDAQ · Biotechnology
Bright Minds Biosciences Inc
$60.98
-0.57 (-0.93%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-55.8% upside
Low Target
$16.82
Average Target
$26.95
High Target
$32.06
Current Price
$60.98
Current
$60.98
$60.98
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Scenario Analysis
Bear Case
$16.82
-72.4%
Low target
Base Case
$26.95
-55.8%
Avg target
Bull Case
$32.06
+-47.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$170.00
-64.1% from high
52-Week Low
$64.62
+-5.6% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |